Mendelian disorders are most commonly caused by mutations identifiable by DNA sequencing. Exonic deletions and duplications can go undetected by sequencing, and their frequency in most Mendelian ...
Clinical testing using various array comparative genomic hybridization platforms is being incorporated rapidly into cytogenetic testing algorithms. Comprehensive validation of these complex assays ...
Microarray based comparative genomic hybridisation (array CGH) is a new technology with uses developing in various diagnostic areas within the NHS. One important context is the investigation of ...
Array comparative genomic hybridization (CGH) is illuminating DNA copy number variations (CNV) throughout the genome to diagnose disease etiology and to help tailor treatment regimens for patients to ...
Acacia Research Corporation has announced that, its CombiMatrix group’s subsidiary, CombiMatrix Molecular Diagnostics (CMDX), has launched its Bacterial Artificial Chromosome (BAC) array Comparative ...
Early efforts to examine genomic changes in the clinical setting relied on cytogenetic techniques such as chromosome karyotyping, a widely used approach to examine chromosomes and identify changes ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today announced that scientists using the company’s comparative genomic hybridization (CGH) technology have shown that cancer ...
Agilent Technologies Inc. has introduced the SurePrint G3 Human CGH+SNP microarray platform, a system for simultaneous analysis of chromosomal copy number changes and copy-neutral aberrations. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback